The Ludwig Boltzmann Gesellschaft, the Medical University of Graz, Bayer HealthCare, NEBU-TEC and the Austrian Academy of Sciences recently established an innovative translational centre for lung vascular diseases.

The LBI Consortium brings together researchers and business partners in the dynamic field of pulmonary vascular biology, vascular diagnostics and reverse-remodelling therapy into a single, multi disciplinary and highly competitive institute. The LBI will favourably combine experimental know-how, innovative imaging techniques and clinical background for high-yield research in an integrated approach in order to develop new diagnostical tools and therapies for pulmonary vascular diseases.

Our Institute is located at the

Center for Medical Research
Stiftingtalstrasse 24
8010 Graz
AUSTRIA

email: office@lvr.lbg.ac.at

Phone: +43 (0)316 385-72057